Register for a free virtual education talk on food and common cancer myths

Join us on Tuesday, March 5, 6–7:00 p.m., when Providence Cancer Institute in partnership with Pink Lemonade Project presents a free virtual education talk on food and common cancer myths. Christina Speaks, MS, RDN, LD, a registered dietitian at Providence Cancer Institute, Oncology Nutrition, is the guest speaker.  

Event details: 

Food + Common Cancer Myths 
Date: Tuesday, March 5, 2024 
Time: 6–7:00 p.m. 
Location: Virtual Event via Zoom 

Register here 

About Christina Speaks: 

Christina’s journey in nutrition began at Sam Houston State University in Huntsville, TX, where she completed her undergraduate and master’s degree with a primary focus in nutrition research and community. She has spent a large part of her career in clinical nutrition, including critical care. Christina enjoys helping people feel confident and knowledgeable about the foods they eat. When she is not working, Christina enjoys distance running, hiking, camping and spending time with her husband and three sons.  

About Providence oncology nutrition services: 

Good nutrition is important during cancer treatment and recovery. Cancer and cancer treatments can affect the way your body tolerates certain foods and uses nutrients. Our registered dietitians specialize in cancer nutrition. They work closely with you to set nutrition goals and advise ways to achieve them. Learn more. 

Related news

A remarkable year of engagement and advancements at Providence Cancer Institute

Register for a free, virtual cancer nutrition class

Keep your colon healthy to prevent disease

Previous Article
FDA approves cellular therapy, offering hope to more people with cancer
FDA approves cellular therapy, offering hope to more people with cancer

The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma tha...

Next Article
Promising results of amivantamab studies appear in high-profile journals
Promising results of amivantamab studies appear in high-profile journals

New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.